DNTH
NASDAQ
US
Dianthus Therapeutics, Inc. - Common Stock
$86,00
▲ +$1,44
(+1,70%)
Vol 880K
3
Skor Kualitas
fail
Pendapatan ✗
Laba Bersih ✗
>IPO ✗
Kap. Pasar
$1.8B
ROE
-33,0%
Margin
-4104,8%
D/E
0,00
Beta
1,57
52W
$13–$45
Konsensus Wall Street
22 analis · Apr 202610
Beli Kuat
11
Beli
1
Tahan
0
Jual
0
Jual Kuat
95,5%
Peringkat Beli
Grafik Harga
Saham Serupa
CELC
Celcuity Inc
$4.6B
TGTX
TG Therapeutics Inc
P/E 10,6
$4.7B
APLS
Apellis Pharmaceuticals Inc
P/E 70,7
$3.2B
IMVT
Immunovant Inc
$5.1B
APGE
Apogee Therapeutics Inc
$5.2B
FOLD
Amicus Therapeutics Inc
$4.4B
VKTX
Viking Therapeutics Inc
$4.0B
ACAD
ACADIA Pharmaceuticals Inc
P/E 17,3
$4.5B
SYRE
Spyre Therapeutics Inc
$2.5B
LEGN
Legend Biotech Corp
$4.0B
Pendapatan
Tingkat beat: 50,0%
Laporan Berikutnya
Mei 11, 2026
Estimasi EPS: $-1,08
| Kuartal | EPS Estimasi | EPS Aktual | Kejutan |
|---|---|---|---|
| Mar 2026 | $-1,08 | — | — |
| Des 2025 | $-1,10 | $-1,43 | $-0,33 |
| Sep 2025 | $-0,88 | $-0,97 | $-0,09 |
| Jun 2025 | $-0,89 | $-0,88 | +$0,01 |
Pendapatan & Laba Kuartalan
| Kuartal | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Pendapatan | $2.2M | $1.3M | $1.2M | $193K | $396K |
| Laba Bersih | -$25.2M | -$28.4M | -$29.5M | -$31.6M | -$36.8M |
Tren Fundamental
| Metrik | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -34.7% | -34.7% | -34.7% | -34.7% | -33.0% | -33.0% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -16388.1% | -2364.1% | -2364.1% | -2364.1% | -4104.8% | -4104.8% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 13.12 | 13.12 | 13.12 | 13.12 | 17.35 | 17.35 |
Rasio Utama
ROA (TTM)
-31,1%
P/S (TTM)
574,05
P/B
1,8
EPS (TTM)
$-3,48
CF/Share
$-14,53
52W High
$45,46
52W Low
$13,37
$13,37
Rentang 52 Minggu
$45,46
Kesehatan Keuangan
Arus Kas Bebas
-$30.6M
Utang Bersih
-$54.7M
Kas
$56.0M
Total Utang
$1.3M
Per tanggal Sep 30, 2025
Як DNTH виглядає на тлі конкурентів у Biotechnology?
Група порівняння: Micro-cap Biotechnology (All) · 528 компаній
Оцінка DNTH vs аналоги Biotechnology
P/E
—
▼
0%
di bawah
rekan
(18,8)
vs Rekan
vs Industri
Undervalued
P/S
574,1
▲
4367%
di atas
rekan
(12,9)
vs Rekan
vs Industri
Overvalued
P/B
1,8
▼
26%
di bawah
rekan
(2,5)
vs Rekan
vs Industri
Lebih mahal
Дивідендна дохідність
—
▼
0%
di bawah
rekan
(0,0%)
vs Rekan
vs Industri
Yield rendah
Прибутковість DNTH vs аналоги Biotechnology
ROE
-33,0%
▲
51%
di atas
rekan
(-67,3%)
vs Rekan
vs Industri
Di bawah rata-rata
Net margin
-4104,8%
▼
1331%
di bawah
rekan
(-286,8%)
vs Rekan
vs Industri
Lemah
Валова маржа
—
▼
0%
di bawah
rekan
(78,6%)
vs Rekan
vs Industri
Sejajar
ROA
-31,1%
▲
33%
di atas
rekan
(-46,7%)
vs Rekan
vs Industri
Di bawah rata-rata
Фінансове здоровʼя DNTH vs аналоги Biotechnology
D/E ratio
0,0
▼
0%
di bawah
rekan
(0,0)
vs Rekan
vs Industri
Utang rendah
Поточна ліквідність
17,4
▲
291%
di atas
rekan
(4,4)
vs Rekan
vs Industri
Likuiditas kuat
Beta
1,6
▲
62%
di atas
rekan
(1,0)
vs Rekan
vs Industri
Lebih volatil
Радар фундаменталів DNTH
DNTH
Median rekan
Industri
DNTH прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
DNTH vs аналоги: ключові метрики
Aktivitas Orang Dalam
NeutralPembelian
0
Penjualan
0
SOTEROPOULOS PAULA
Director · Mar 24
27594 shs
SOTEROPOULOS PAULA
Director · Mar 24
27594 shs
GARCIA MARINO
Chief Executive Officer · Mar 16
65292 shs
CARR EDWARD
Officer · Mar 12
43682 shs
GARCIA MARINO
Chief Executive Officer · Mar 12
122918 shs
RANDHAWA SIMRAT
Officer · Mar 12
33830 shs
CARR EDWARD
Officer · Mar 12
43682 shs
GARCIA MARINO
Chief Executive Officer · Mar 12
122918 shs
RANDHAWA SIMRAT
Officer · Mar 12
33830 shs
Terakhir 90 hari
Pemegang Terbesar
Top 5: 35,06%FMR, LLC
14,46%
$521.8M
Wellington Management Group…
5,63%
$203.1M
Octagon Capital Advisors LP
5,43%
$196.1M
Fairmount Funds Management …
4,81%
$173.4M
Avidity Partners Management…
4,73%
$170.7M
Per tanggal Des 31, 2025